NEW YORK (GenomeWeb News) – Cellular Dynamics today said that it has licensed exclusive rights to a patent portfolio covering the optimization of the stem cell differentiation selection process and the use of heart cells in drug testing.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.